Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

PRM-151 in Myelofibrosis: Durable Efficacy and Safety at 72 Weeks

Srdan Verstovsek, MD, Ruben A. Mesa, Lynda M Foltz, MD, Vikas Gupta, MD MRCP, MRCPath, John O. Mascarenhas, MD MS, Ellen K. Ritchie, MD, Ronald Hoffman, MD, Richard T. Silver, MD, Marina Kremyanskaya, MDPhD, Olga Pozdnyakova, MD, Robert P. Hasserjian, MD, Elizabeth Trehu, MD, Mohamed E Salama, MD, Hagop M Kantarjian, MD, Jason Gotlib, MD

Blood (2015) 126 (23): 56.

https://doi.org/10.1182/blood.V126.23.56.56

Published: 2015

Journal Articles

Propensity Score Matching Analysis Comparing Reduced Intensity Versus Myeloablative Conditioning in AML/MDS Patients Transplanted with Fludarabine-Busulfan-Low Dose Total Body Irradiation Based Regimen

Hassan Sibai, Fotios V. Michelis, MDPhD, Nada Hamad, MBBS Hons, FRACP, FRCPA, Jieun Uhm, MD, Vikas Gupta, MD MRCP, MRCPath, John G. Kuruvilla, MD, Jeffrey H. Lipton, MD PhD, Hans A. Messner, PhD, Matthew D. Seftel, MBChB, FRCP(C), MRCP, Dennis Dong Hwan Kim, MDPhD

Blood (2014) 124 (21): 3870.

https://doi.org/10.1182/blood.V124.21.3870.3870

Published: 2014

Journal Articles

Second Unrelated Donor (URD) Transplant as a Rescue Strategy for 122 Patients with Primary Non Engraftment: Results from the CIBMTR

Jeffrey R. Schriber, MD, Manza- A Agovi, MPH, Karen K Ballen, MD, Andrea Bacigalupo, MD, Gregory A. Hale, MD, Vikas Gupta, MD, MRCP, MRCPath, Hillard M. Lazarus, MD, Mark R. Litzow, MD, David I. Marks, MD, Roger H. Giller, MD, Richard T. Maziarz, MD, Martin Bornhauser, MD, Luis M. Isola, MD, Christopher Bredeson, MD, J. Douglas Rizzo, MD, MS

Blood (2008) 112 (11): 794.

https://doi.org/10.1182/blood.V112.11.794.794

Published: 2008

Journal Articles

Outcome of Patients Age 60 and Over with Acute Lymphoblastic Leukemia (ALL) Treated with a Modified Pediatric Protocol

Susan Kao, MD, Wei Xu, PhD, Vikas Gupta, MD, MRCP, MRCPath, Mark Minden, Andre Schuh, MD, Aaron D. Schimmer, Karen WL Yee, Joseph Brandwein, MD, FRCPC

Blood (2008) 112 (11): 3962.

https://doi.org/10.1182/blood.V112.11.3962.3962

Published: 2008

Journal Articles

Subcutaneous Alemtuzumab Is a Safe and Effective Treatment for Global or Single-Lineage Immune-Mediated Marrow Failures: a Survey from the EBMT-WPSAA

Antonio M. Risitano, MD, PhD, Elisa Seneca, Ludovica Marando, Bianca Serio, Carmine Selleri, Giulia Scalia, Luigi Del Vecchio, MD, Annapaola Iori, M.D., Alexander Kulagin, Sebastien Maury, Joerg Halter, Vikas Gupta, MD, MRCP, MRCPath, Andrea Bacigalupo, MD, Gerard Socié, Andre Tichelli, Judith Marsh, Hubert Schrezenmeier, Jakob R. Passweg, MD, MS, Bruno Rotoli

Blood (2008) 112 (11): 1042.

https://doi.org/10.1182/blood.V112.11.1042.1042

Published: 2008

Journal Articles

Similar 5-Year Survival after Peripheral Blood Autotransplants (AutoPB) Versus HLA Matched Sibling Myeloablative Transplants (AlloBMT) for Acute Myeloid Leukemia (AML) in First Complete Remission (CR1).

Armand Keating, MD, Manisha Kukreja, MBBS, MPH, Gisela Tunes da Silva, PhD, Vikas Gupta, MD, MRCP, MRCPath, Corey Cutler, MD, MPH, Martin S. Tallman, MD, Jorge Sierra, MD, John F. DiPersio, MD, PhD, Mary M. Horowitz, MD, MS, Daniel J. Weisdorf, MD

Blood (2008) 112 (11): 2168.

https://doi.org/10.1182/blood.V112.11.2168.2168

Published: 2008

Journal Articles

Hematopoietic Recovery and Overall Survival after HLA-Matched Sibling Transplants for Older Patients with Severe Aplastic Anemia (SAA).

Vikas Gupta, MD, MRCP, MRCPath, Jeanette Carreras, MPH, Ruta Bajorunaite, PhD, Robert Peter Gale, MD, PhD, DSc, Mitchell Sabloff, MDCM, FRCPC, MSc, Mahmoud Aljurf, MD, Hubert Schrezenmeier, MD, Gerard Socié, MD, Jakob Passweg, MD, MS, Olle Ringdén, MD, Ricardo Pasquini, MD, Judith Marsh, MD, Mary Eapen, MBBS

Blood (2008) 112 (11): 2169.

https://doi.org/10.1182/blood.V112.11.2169.2169

Published: 2008

Journal Articles

Transplantation-Specific Cytogenetics Grouping Scheme for Patients with Myelodysplastic Syndromes: A Multicenter Validation Study

Philippe Armand, MD, PhD, H. Joachim Deeg, Haesook T. Kim, PhD, Hun Lee, MD, Paul Armistead, MD, PhD, Marcos De Lima, MD, Vikas Gupta, MD, MRCP, MRCPath, Robert J. Soiffer, MD

Blood (2008) 112 (11): 2673.

https://doi.org/10.1182/blood.V112.11.2673.2673

Published: 2008

Journal Articles

Obesity Does Not Preclude Safe and Effective Myeloablative Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML) in Adults

Willis H. Navarro, MD, Manza-A Agovi, MPH, Brent Logan, PhD, Andrea Bacigalupo, MD, Karen K Ballen, MD, Brian J. Bolwell, MD, Haydar Frangoul, MD, Vikas Gupta, MD, MRCP, MRCPath, Theresa Hahn, PhD, Mark Juckett, MD, Hillard M. Lazarus, MD, Mark R. Litzow, MD, Jane Liesveld, MD, Jan Moreb, MD, David Marks, MD, PhD, Philip L. McCarthy, MD, J. Douglas Rizzo, MD, MS

Blood (2008) 112 (11): 51.

https://doi.org/10.1182/blood.V112.11.51.51

Published: 2008

NARROW

PRM-151 in Myelofibrosis: Durable Efficacy and Safety at 72 Weeks

Propensity Score Matching Analysis Comparing Reduced Intensity Versus Myeloablative Conditioning in AML/MDS Patients Transplanted with Fludarabine-Busulfan-Low Dose Total Body Irradiation Based Regimen

Second Unrelated Donor (URD) Transplant as a Rescue Strategy for 122 Patients with Primary Non Engraftment: Results from the CIBMTR

Outcome of Patients Age 60 and Over with Acute Lymphoblastic Leukemia (ALL) Treated with a Modified Pediatric Protocol

Subcutaneous Alemtuzumab Is a Safe and Effective Treatment for Global or Single-Lineage Immune-Mediated Marrow Failures: a Survey from the EBMT-WPSAA

Similar 5-Year Survival after Peripheral Blood Autotransplants (AutoPB) Versus HLA Matched Sibling Myeloablative Transplants (AlloBMT) for Acute Myeloid Leukemia (AML) in First Complete Remission (CR1).

Hematopoietic Recovery and Overall Survival after HLA-Matched Sibling Transplants for Older Patients with Severe Aplastic Anemia (SAA).

Transplantation-Specific Cytogenetics Grouping Scheme for Patients with Myelodysplastic Syndromes: A Multicenter Validation Study

Obesity Does Not Preclude Safe and Effective Myeloablative Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML) in Adults

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only